glp 1 for mash Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Unequivocally yes': MASH therapies still
Description
These are no longer endocrinology or primary care drugs
However, practical considerations exist regarding gastrointestinal tolerability
In studies with multiple treatment arms, including combination therapies and monotherapies with either SGLT-2i, GLP-1RA, or TAU, we restructured these into separate comparisons
Wong was surprised to find that GLP-1 agonists only reduced inflammation in the mice when their hormone's brain receptors remained unblocked
